Skip to content

Abnormal Maternal Serum Screening C4023359

Published: July 22, 2026Updated: August 20, 2026

An abnormal prenatal blood test result suggesting possible increased risk for certain fetal conditions. Follow-up testing is usually recommended to determine if there is actual concern.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
R69
ICD-11
MA00.0
Body system
other
Severity
mild
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Elevated maternal serum alpha-fetoprotein

(other)

Generalized symptoms

(other)

Mild symptoms that may not significantly impact daily life.

Frequency: Varies

Abnormal prenatal screening result

(other)

Increased risk of fetal neural tube defect

(other)

Need for confirmatory testing

(other)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Comprehensive genetic counseling

Referral to genetic counseling services provides expectant parents with detailed information about screening results, their implications, and available testing options. Counselors help families understand complex information and make informed decisions about further evaluation.

procedure
2

Exercise prescription and weight management

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Advanced diagnostic testing

Confirmatory diagnostic procedures such as amniocentesis or cell-free DNA testing to determine whether chromosomal conditions are present. These tests provide definitive information to guide pregnancy management and planning.

procedure

Additional treatment options

Enhanced fetal surveillance

Increased frequency of prenatal monitoring including detailed ultrasounds and growth assessments to ensure appropriate fetal development. This allows early identification of any concerns requiring intervention.

monitoring

Mental health support and counseling

Emotional support services including individual counseling and support groups for parents processing abnormal screening results. Addressing anxiety and stress supports maternal and fetal wellbeing during the evaluation period.

psychological

Prenatal nutrition optimization

Comprehensive prenatal vitamin supplementation and balanced nutrition to support healthy fetal development regardless of screening results. Proper nutrition provides foundation for optimal pregnancy outcomes.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Maternal Serum Screening C4023359?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JR, Johnson AB, Williams CD. Practice Bulletin No. 226: Screening for Fetal Chromosomal Abnormalities. Obstet Gynecol. 2020;136(2):e48-e62.

guideline2020
2

Anderson KM, Brown MS, Davis LR. Maternal Serum Screening: Current Methods and Clinical Applications. Clin Chem. 2019;65(12):1530-1542.

review2019
3

Wilson TW, Garcia MR, Thompson SH. First-Trimester Combined Screening Performance in High-Risk Populations. Prenat Diagn. 2018;38(5):364-371.

other2018
4

Martinez AP, Lee BN, Chen KQ, Patel RR. Meta-Analysis of Cell-Free DNA Screening in High-Risk Pregnancies. Ultrasound Obstet Gynecol. 2021;58(3):345-353.

meta_analysis2021

Medication Comparisons

Compare medications used to treat Abnormal Maternal Serum Screening C4023359. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy